Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Differences in Thrombolytic Effects of Administrated Recombinant t-PA between Japanese and Caucasians

1 Jan 2002

Abstract excerpt

The Differences in Thrombolytic Effects of Administrated Recombinant t-PA between Japanese and Caucasians -

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Ischemic Stroke Management
Share to Antiplatelet Therapy and Cardiovascular Diseases
Share to Atrial Fibrillation Management and Outcomes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 11916094
DOI: 10.1055/s-0037-1613042

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

The Differences in Thrombolytic Effects of Administrated Recombinant t-PA between Japanese and CaucasiansPMID 11916094Read ↗

Strategies for the improvement of thrombolytic agents.Semantic proximity Read ↗

Safety and efficacy of low-dose rt-PA with tirofiban to treat acute non-cardiogenic stroke: A single-center controlled studySemantic proximity Read ↗

Pharmacological and clinical impact of the unique molecular structure of a new plasminogen activator.Semantic proximity Read ↗

[Biochemical, pharmacologic and clinical properties of new thrombolytic agents].Semantic proximity Read ↗

[Mutant t-PA compared with native t-PA in acute myocardial infarction].Semantic proximity Read ↗

Thrombolytic and pharmacokinetic properties of human tissue-type plasminogen activator variants, obtained by deletion and/or duplication of structural/functional domains, in a hamster pulmonary embolism model.Semantic proximity Read ↗

Thrombolytic properties in a rabbit jugular vein thrombosis model of a tissue-type plasminogen activator mutant lacking the growth factor--and kringle one-domains.Semantic proximity Read ↗

Angiographic study of mutant tissue-type plasminogen activator versus urokinase for acute myocardial infarction.Semantic proximity Read ↗

Newer thrombolytic agents.Semantic proximity Read ↗

Comparative study of a mutant tissue-type plasminogen activator, YM866, with a tissue-type plasminogen activator in a canine model of femoral arterial thrombosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.